A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Treatment Acquiring Traction Online
The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in individuals injecting substances of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.
Platform Response and Content Removal
According to the social media company, the service has taken down violative material and banned associated hashtags and query recommendations. The company said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.
Online Marketplace Operations
Investigations also found communities with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with numerous of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
Within moments of entering one group, a seller shared WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or past usage.
Item Details and Costs
Inside these communities, messages display dark colored packages with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service stated it regularly moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already seen patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose patients to potentially serious medical dangers”.
